Activist 13D/13G Filings - Versant Venture Capital V L.P.

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-08-03
4:41 pm
Purchase
13DTurnstone Biologics Corp.
TSBX
Versant Venture Capital V L.P.2,899,216
12.5%
2,899,216increase
(New Position)
View
2023-02-09
4:30 pm
Unchanged
13GGritstone bio, Inc.
GRTS
Versant Venture Capital V L.P.2,895,695
3.5%
0
(Unchanged)
View
2023-01-06
4:19 pm
Sale
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.2,094,451
5%
-250,000decrease
(-10.66%)
View
2022-06-13
4:38 pm
Sale
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.2,344,451
5.6%
-250,000decrease
(-9.64%)
View
2022-02-10
8:21 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V L.P.382,961
0.8%
-1,512,041decrease
(-79.79%)
View
2022-02-10
7:58 pm
Unchanged
13GGritstone bio, Inc.
GRTS
Versant Venture Capital V L.P.2,895,695
4.3%
0
(Unchanged)
View
2021-08-16
4:57 pm
Unchanged
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.2,594,451
7%
0
(Unchanged)
View
2021-04-19
6:05 pm
Purchase
13DVectivBio Holding AG
VECT
Versant Venture Capital V L.P.2,791,748
8.2%
2,791,748increase
(New Position)
View
2021-02-26
4:36 pm
Sale
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.2,594,451
7.1%
-550,000decrease
(-17.49%)
View
2021-02-16
07:30 am
Unchanged
13GGritstone bio, Inc.
GRTS
Versant Venture Capital V L.P.2,895,695
6.1%
0
(Unchanged)
View
2021-02-12
8:27 pm
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V L.P.1,895,002
5.8%
-789,560decrease
(-29.41%)
View
2021-01-25
4:27 pm
Sale
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.3,144,451
8.6%
-275,000decrease
(-8.04%)
View
2020-07-06
9:31 pm
Purchase
13DRepare Therapeutics Inc.
RPTX
Versant Venture Capital V L.P.3,419,451
9.3%
3,419,451increase
(New Position)
View
2020-02-14
11:39 am
Sale
13GCrinetics Pharmaceuticals, Inc.
CRNX
Versant Venture Capital V L.P.2,684,562
10.9%
-473,689decrease
(-15.00%)
View